XML 175 R157.htm IDEA: XBRL DOCUMENT v3.19.1
Schedule I Financial Information - Statements of Cash Flows (Details) - USD ($)
$ in Thousands
1 Months Ended 11 Months Ended 12 Months Ended
Feb. 09, 2018
Dec. 31, 2018
Dec. 31, 2017
Investing activities      
Principal payments and proceeds received on mortgage loans held for investment $ 8,880 $ 229,748 $ 161,419
Purchases of premises and equipment (268) (4,210) (6,141)
Proceeds from the sale of residual interests in Residual Trusts, net 0 29,924 0
Other (1,563) 6,028 5,172
Financing activities      
Payments on corporate debt (110,590) (157,645) (186,910)
Other debt issuance costs paid (10,472) (16,206) (49,305)
Other 0 113 (1,603)
Cash and cash equivalents and restricted cash and cash equivalents at beginning of the period 398,795 248,464 429,061
Cash and cash equivalents and restricted cash and cash equivalents at end of the period 248,464 253,135 398,795
Parent Company [Member]      
Cash flows used in operating activities (30,622) (97,036) (71,410)
Investing activities      
Principal payments and proceeds received on mortgage loans held for investment 26 776 1,443
Purchases of premises and equipment 0 0 (1,099)
Capital contributions to subsidiaries and VIEs (741) (10,564) (102,897)
Returns of capital from subsidiaries and VIEs 2 2,446 223,999
Change in due from affiliates 77,262 (65,744) 171,805
Proceeds from the sale of residual interests in Residual Trusts, net 0 45,250 0
Other (5) 8,670 11,861
Cash flows provided by (used in) investing activities 76,544 (19,166) 305,112
Financing activities      
Payments on corporate debt (110,590) (157,645) (186,910)
Other debt issuance costs paid 0 (11,065) (32,573)
Change in due to affiliates 64,866 285,162 (14,409)
Other 0 0 (76)
Cash flows provided by (used in) financing activities (45,724) 116,452 (233,968)
Net increase (decrease) in cash and cash equivalents and restricted cash and cash equivalents 198 250 (266)
Cash and cash equivalents and restricted cash and cash equivalents at beginning of the period 2,009 2,207 2,275
Cash and cash equivalents and restricted cash and cash equivalents at end of the period $ 2,207 $ 2,457 $ 2,009